Compare · ALC vs WRBY
ALC vs WRBY
Side-by-side comparison of Alcon Inc. (ALC) and Warby Parker Inc. (WRBY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALC and WRBY operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- ALC is the larger of the two at $34.48B, about 10.3x WRBY ($3.36B).
- Over the past year, ALC is down 23.2% and WRBY is up 19.2% - WRBY leads by 42.4 points.
- WRBY has been more active in the news (9 items in the past 4 weeks vs 1 for ALC).
- Both have 25 recent analyst ratings on file.
- Company
- Alcon Inc.
- Warby Parker Inc.
- Price
- $67.10-2.74%
- $27.41-0.05%
- Market cap
- $34.48B
- $3.36B
- 1M return
- +0.84%
- +5.91%
- 1Y return
- -23.16%
- +19.23%
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NYSE
- NYSE
- IPO
- 2019
- 2021
- News (4w)
- 1
- 9
- Recent ratings
- 25
- 25
Alcon Inc.
Alcon, Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; and EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, including devices and over-the-counter products for dry eye, over-the-counter products for contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon, Inc. in December 2001. Alcon, Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Warby Parker Inc.
Warby Parker Inc. designs, manufactures, and retails eyewear products for men and women. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as eye exams and vision tests. As of June 30, 2021, it operated 145 retail stores, which included 142 locations in the United States and 3 locations in Canada, as well as online stores. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
Latest ALC
- Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
- SEC Form SD filed by Alcon Inc.
- SEC Form 6-K filed by Alcon Inc.
- New Product Launches Drive Alcon's First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds
- Alcon Announces Results of 2026 Annual General Meeting
- Systane Steps Up to the Plate as the Official Eye Drop of the Toronto Blue Jays, Raising Awareness of Dry Eye in Canada
- Alcon Launches Clareon TruPlus, Enhanced Design Monofocal and Toric IOLs, at ASCRS 2026
- SEC Form 6-K filed by Alcon Inc.
- Alcon Publishes Agenda for 2026 Annual General Meeting
- Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement
Latest WRBY
- Co-Chief Executive Officer Blumenthal Neil Harris converted options into 9,200 shares and sold $275,908 worth of shares (9,200 units at $29.99) as part of a pre-agreed trading plan (SEC Form 4)
- Co-Chief Executive Officer Gilboa David Abraham converted options into 54,347 shares and sold $1,621,714 worth of shares (54,347 units at $29.84) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 144 filed by Warby Parker Inc.
- Co-Chief Executive Officer Blumenthal Neil Harris converted options into 189,320 shares and sold $6,445,120 worth of shares (217,667 units at $29.61) as part of a pre-agreed trading plan, decreasing direct ownership by 48% to 31,112 units (SEC Form 4)
- Co-Chief Executive Officer Gilboa David Abraham converted options into 213,746 shares and sold $7,191,541 worth of shares (242,221 units at $29.69) as part of a pre-agreed trading plan, decreasing direct ownership by 48% to 31,112 units (SEC Form 4)
- Director Raider Jeffrey Jacob sold $668,700 worth of shares (22,500 units at $29.72) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 435,201 units (SEC Form 4)
- Co-Chief Executive Officer Blumenthal Neil Harris converted options into 36,300 shares and sold $1,090,452 worth of shares (36,300 units at $30.04) as part of a pre-agreed trading plan (SEC Form 4)
- BofA Securities initiated coverage on Warby Parker with a new price target
- SEC Form 4 filed by Co-Chief Executive Officer Blumenthal Neil Harris
- Director Briggs Teresa sold $129,683 worth of shares (5,000 units at $25.94) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 48,883 units (SEC Form 4)